Von Willebrand Disease News

My Baby Brought Me Joy and a Life-Altering Diagnosis - Huffington Post (blog)



My Baby Brought Me Joy and a Life-Altering Diagnosis 
Huffington Post (blog)
Shortly after Lynden's birth I was diagnosed with von Willebrand disease (VWD), a hereditary bleeding disorder that I had unknowingly struggled with my whole life. According to the US Centers for Disease Control, VWD may affect 1 percent of the ...

 


Diagnosis improves quality of life for those with bleeding disorder - Local 10



Diagnosis improves quality of life for those with bleeding disorder 
Local 10
Kristin was silently suffering from the most common hereditary bleeding disorder, von Willebrand disease (VWD). The US Centers for Disease Control estimates that VWD affects up to 1 percent of the US population, with many misdiagnosed or undiagnosed.

and more » 


Baxter receives Chinese approval for haemophilia A drug, Advate - pharmabiz.com



Baxter receives Chinese approval for haemophilia A drug, Advate 
pharmabiz.com
Advate is not indicated for the treatment of von Willebrand disease. Haemophilia is a rare genetic blood clotting disorder that primarily affects males. People living with haemophilia do not have enough of, or are missing, one of the blood clotting ...

and more » 


Middle and posterior cardiac veins: An underused option for ventricular pacing - The Journal of Thoracic and Cardiovascular Surgery



Middle and posterior cardiac veins: An underused option for ventricular pacing 
The Journal of Thoracic and Cardiovascular Surgery
His history was otherwise notable for possible von Willebrand disease. He had anticoagulation with warfarin sodium (INN warfarin), a regimen that was converted to unfractionated heparin before the procedure. On clinical grounds, a transvenous approach ...

 


Analysis Finds Safety of 4-Factor Prothrombin Complex Concentrate Is ... - MarketWatch (press release)



Analysis Finds Safety of 4-Factor Prothrombin Complex Concentrate Is ... 
MarketWatch (press release)
CSL Behring therapies are indicated for the treatment of coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease. The company's products are also used ...

and more » 


CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase ... - MarketWatch (press release)



CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase ... 
MarketWatch (press release)
CSL Behring therapies are indicated for the treatment of coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease. The company's products are also used ...

and more » 


Young nurses celebrate week with pride - Rochester Democrat and Chronicle



Young nurses celebrate week with pride 
Rochester Democrat and Chronicle
DeRider said she coordinates patient care for both children and adults with bleeding disorders such as hemophilia, von Willebrand disease, platelet disorders and hemochromatosis. And DeRider said she loves her job as a nurse and her work environment ...

 


Runners take to Lansdale streets for Broad Street ReRun - Montgomery Newspapers



Runners take to Lansdale streets for Broad Street ReRun 
Montgomery Newspapers
... fourth annual Broad Street Rerun in Lansdale. The event is held as a fundraiser to support the Delaware Valley Chapter of the National Hemophilia Foundation. Alex Rowe, a young boy with Severe von Willebrand disease, is the inspiration behind this run.

 


Analysis Finds Safety of 4-Factor Prothrombin Complex Concentrate Is ... - PR Newswire (press release)



Analysis Finds Safety of 4-Factor Prothrombin Complex Concentrate Is ... 
PR Newswire (press release)
CSL Behring therapies are indicated for the treatment of coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease. The company's products are also used ...

and more » 


CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase ... - PR Newswire (press release)



CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase ... 
PR Newswire (press release)
CSL Behring therapies are indicated for the treatment of coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease. The company's products are also used ...

and more »